Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study to evaluate the safety and tolerability of Camizestrant in combination with Atirmociclib in women with advanced breast cancer. The trial status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Atirmociclib (atirmociclib)
• Camizestrant

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING